These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36000613)
1. Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs. Eberhardy AC; Heinrich NA; McFadden RA; Reiter LV Vet Dermatol; 2022 Dec; 33(6):503-508. PubMed ID: 36000613 [TBL] [Abstract][Full Text] [Related]
2. Incidence, timing, and risk factors of azathioprine hepatotoxicosis in dogs. Wallisch K; Trepanier LA J Vet Intern Med; 2015; 29(2):513-8. PubMed ID: 25641386 [TBL] [Abstract][Full Text] [Related]
3. A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. Jack KL; Koopman WJ; Hulley D; Nicolle MW J Clin Neuromuscul Dis; 2016 Sep; 18(1):12-20. PubMed ID: 27552384 [TBL] [Abstract][Full Text] [Related]
4. Clinical and histologic features of Azathioprine-induced hepatotoxicity. Siramolpiwat S; Sakonlaya D Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864 [TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients. Shaye OA; Yadegari M; Abreu MT; Poordad F; Simon K; Martin P; Papadakis KA; Ippoliti A; Vasiliauskas E; Tran TT Am J Gastroenterol; 2007 Nov; 102(11):2488-94. PubMed ID: 17764490 [TBL] [Abstract][Full Text] [Related]
6. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). Wang A; Smith JR; Creevy KE J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827 [TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Palace J; Newsom-Davis J; Lecky B Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727 [TBL] [Abstract][Full Text] [Related]
8. Azathioprine therapy for acquired myasthenia gravis in five dogs. Dewey CW; Coates JR; Ducoté JM; Meeks JC; Fradkin JM J Am Anim Hosp Assoc; 1999; 35(5):396-402. PubMed ID: 10493415 [TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non-associative immune-mediated thrombocytopenia: 20 cases (2008-2021). Spear DJ; Crouse ZJ; Kearns SA J Small Anim Pract; 2024 Apr; 65(4):261-269. PubMed ID: 38433454 [TBL] [Abstract][Full Text] [Related]
10. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids, Cyclosporine, Azathioprine, Chlorambucil, and Mycophenolate in Dogs and Cats: Clinical Uses, Pharmacology, and Side Effects. Viviano KR Vet Clin North Am Small Anim Pract; 2022 May; 52(3):797-817. PubMed ID: 35379498 [TBL] [Abstract][Full Text] [Related]
12. Combination of Prednisolone and Azathioprine for Steroid-Responsive Meningitis-Arteritis Treatment in Dogs. Giraud L; Girod M; Cauzinille L J Am Anim Hosp Assoc; 2021 Jan; 57(1):1-7. PubMed ID: 33260200 [TBL] [Abstract][Full Text] [Related]
13. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. Vianna RN; Ozdal PC; Deschênes J; Burnier MN Can J Ophthalmol; 2006 Apr; 41(2):183-9. PubMed ID: 16767205 [TBL] [Abstract][Full Text] [Related]
14. Azathioprine-induced bone marrow toxicity in four dogs. Rinkardt NE; Kruth SA Can Vet J; 1996 Oct; 37(10):612-3. PubMed ID: 8896876 [No Abstract] [Full Text] [Related]
15. Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)*. Hosoya K; Lord LK; Lara-Garcia A; Kisseberth WC; London CA; Couto CG Vet Comp Oncol; 2009 Dec; 7(4):244-55. PubMed ID: 19891695 [TBL] [Abstract][Full Text] [Related]
16. Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Gisbert JP; Luna M; González-Lama Y; Pousa ID; Velasco M; Moreno-Otero R; Maté J Inflamm Bowel Dis; 2007 Sep; 13(9):1106-14. PubMed ID: 17455203 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis. Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741 [TBL] [Abstract][Full Text] [Related]
18. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. Rumbo C; Emerick KM; Emre S; Shneider BL J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):391-8. PubMed ID: 12352536 [TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Wagoner LE; Olsen SL; Bristow MR; O'Connell JB; Taylor DO; Lappe DL; Renlund DG Transplantation; 1993 Dec; 56(6):1415-8. PubMed ID: 8279012 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease. Ansari A; Elliott T; Baburajan B; Mayhead P; O'Donohue J; Chocair P; Sanderson J; Duley J Aliment Pharmacol Ther; 2008 Sep; 28(6):734-41. PubMed ID: 19145729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]